Where do Relmada Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Relmada Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Returns
Return on equity	-48.8%+111pp	-94%+38.3pp	-196.8%-80.2pp	-175.1%-74.7pp	-160.3%-64.8pp
Return on assets	-44.8%+90.3pp	-82.1%+29.5pp	-159.1%-54.2pp	-147.2%-57.3pp	-135.1%-49.4pp
Liquidity
Current ratio	18.3×+13.0×	14.6×+10.2×	2.9×-4.0×	4.1×-3.3×	5.3×-1.5×
Quick ratio	18.3×+13.0×	14.6×+10.2×	2.9×-4.0×	4.1×-3.3×	5.3×-1.5×
Cash ratio	0.8×+0.5×	0.5×+0.2×	0.3×+0.1×	0.3×0.0×	0.2×+0.1×
Per Share
Book value per share	$2.53+242%	$2.19+86.1%	$0.29-81.9%	$0.48-76.4%	$0.74-69.1%
Valuation
Market capitalization	$677.17M+2,907%	$354.2M+2,157%	$66.72M-31.8%	$19.65M-78.3%	$8.96M-93.6%
Price / book	3.1×+2.1×	4.1×+3.7×	7×+5.0×	1.2×-0.2×	0.4×-1.5×
Earnings yield	-8.7%+327pp	-16.2%+494pp	-84.2%+4.3pp	-345.2%-249pp	-844.8%-778pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Relmada Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Relmada Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.